New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alector, Inc.
ALEC
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

451M

Biotechnology

Next Earning date - 05 Nov 2024

451M

Biotechnology

Next Earning date - 05 Nov 2024

4.63USD
Shape-0.07 ( -1.49%)
Market Open
favorite-chart

Relative Strenght

13
favorite-chart

Volume Buzz

-79%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

48%

Quote Panel

Shape
Updated October 23, 2024
1W -10.29 % 1M -11.15 % 3M -27.01 % 1Y -12.50 %

Key Metrics

Shape
  • Market Cap

    450.60M


  • Shares Outstanding

    97.32M


  • Share in Float

    74.86M


  • Dividende

    0


  • Earning Date

    05 Nov 2024


  • Price Target

    4.63


  • Average Volume

    497454


  • Beta

    0.675


  • Range

    3.66-8.9


  • Industry

    Biotechnology


  • Website

    https://www.alector.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

8.29x

P/S Ratio

3.02x

P/B Ratio

0.2

Debt/Equity

-290.7%

Net Margin

$-1.8

EPS

How ALEC compares to sector?

P/E Ratio

Relative Strength

Shape

ALEC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$127M

Shape744%

2025-Revenue

$1.35

Shape-236%

2025-EPS

$106M

Shape-146%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Keefe, Bruyette & Woods

upgrade

Previous: Not converted

2023-12-14

Now: Buy

Morgan Stanley

downgrade

Previous: Not converted

2022-09-09

Now: Equal-Weight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.56
vs 1.49

Q4.22

arrow
arrow

N/A

-0.63
vs -0.68

Q1.23

arrow
arrow

N/A

-0.55
vs -0.54

Q2.23

arrow
arrow

-83%

0.02
vs 0.12

Q3.23

arrow
arrow

N/A

-0.53
vs -0.56

Q4.23

arrow
arrow

N/A

-0.49
vs -0.63

Q1.24

arrow
arrow

N/A

-0.38
vs -0.55

Q2.24

arrow
arrow

N/A

-0.40
vs 0.02

Q3.24

arrow
arrow

N/A

-0.53
vs -0.53

Q4.24

arrow
arrow

N/A

-0.59
vs -0.49

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-92%

14.9M  vs 182.4M

Q4.22

arrow
arrow

+3%

14.4M  vs 14M

Q1.23

arrow
arrow

-32%

16.5M  vs 24.5M

Q2.23

arrow
arrow

-30%

56.2M  vs 79.9M

Q3.23

arrow
arrow

-39%

9.1M  vs 14.9M

Q4.23

arrow
arrow

+5%

15.2M  vs 14.4M

Q1.24

arrow
arrow

-4%

15.9M  vs 16.5M

Q2.24

arrow
arrow

-73%

15.1M  vs 56.2M

Q3.24

arrow
arrow

+72%

15.7M  vs 9.1M

Q4.24

arrow
arrow

+5%

15.9M  vs 15.2M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-18%

-0.18
vs 0.03

Q4.22

arrow
arrow

-24%

-0.24
vs -0.18

Q1.23

arrow
arrow

-25%

-0.25
vs -0.24

Q2.23

arrow
arrow

+1%

0.01
vs -0.25

Q3.23

arrow
arrow

-27%

-0.27
vs 0.01

Q4.23

arrow
arrow

-31%

-0.31
vs -0.27

Q1.24

arrow
arrow

-20%

-0.20
vs -0.31

Q2.24

arrow
arrow

-26%

-0.26
vs -0.20

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

166

166
vs 154

8%

Q4.22

arrow
arrow

156

156
vs 166

-6%

Q1.23

arrow
arrow

149

149
vs 156

-4%

Q2.23

arrow
arrow

144

144
vs 149

-3%

Q3.23

arrow
arrow

149

149
vs 144

3%

Q4.23

arrow
arrow

150

150
vs 149

1%

Q1.24

arrow
arrow

158

158
vs 150

5%

Q2.24

arrow
arrow

161

161
vs 158

2%

Earnings Growth

Latest News